vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and First Foundation Inc. (FFWM). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $48.4M, roughly 1.7× First Foundation Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -97.9%, a 104.7% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 117.4%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-35.2M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
BLLN vs FFWM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $48.4M |
| Net Profit | $5.7M | $-8.0M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | -97.5% |
| Net Margin | 6.8% | -97.9% |
| Revenue YoY | 117.4% | 421.7% |
| Net Profit YoY | 138.3% | 43.0% |
| EPS (diluted) | $0.10 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $48.4M | ||
| Q3 25 | $83.5M | $63.6M | ||
| Q2 25 | — | $51.4M | ||
| Q1 25 | — | $71.4M | ||
| Q4 24 | — | $9.3M | ||
| Q3 24 | $38.4M | $9.2M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | — | $51.1M |
| Q4 25 | — | $-8.0M | ||
| Q3 25 | $5.7M | $-146.3M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $-14.1M | ||
| Q3 24 | $-14.9M | $-82.2M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $793.0K |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -97.5% | ||
| Q3 25 | 11.5% | -92.7% | ||
| Q2 25 | — | -21.1% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | -247.7% | ||
| Q3 24 | -32.9% | -1276.7% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | -0.2% |
| Q4 25 | — | -97.9% | ||
| Q3 25 | 6.8% | -230.1% | ||
| Q2 25 | — | -15.0% | ||
| Q1 25 | — | 9.7% | ||
| Q4 24 | — | -152.2% | ||
| Q3 24 | -38.8% | -896.9% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $0.10 | $-1.78 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | $-1.47 | $-1.23 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $1.6B |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $912.6M |
| Total Assets | $327.5M | $11.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.6B | ||
| Q3 25 | $195.2M | $1.7B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $912.6M | ||
| Q3 25 | $-239.5M | $917.9M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $-242.9M | $1.1B | ||
| Q2 24 | — | $933.2M | ||
| Q1 24 | — | $928.7M |
| Q4 25 | — | $11.9B | ||
| Q3 25 | $327.5M | $11.9B | ||
| Q2 25 | — | $11.6B | ||
| Q1 25 | — | $12.6B | ||
| Q4 24 | — | $12.6B | ||
| Q3 24 | — | $13.4B | ||
| Q2 24 | — | $13.7B | ||
| Q1 24 | — | $13.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-31.9M |
| Free Cash FlowOCF − Capex | $6.5M | $-35.2M |
| FCF MarginFCF / Revenue | 7.7% | -72.8% |
| Capex IntensityCapex / Revenue | 8.8% | 6.9% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-45.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-31.9M | ||
| Q3 25 | $13.8M | $9.2M | ||
| Q2 25 | — | $-16.3M | ||
| Q1 25 | — | $-552.0K | ||
| Q4 24 | — | $-8.7M | ||
| Q3 24 | — | $14.2M | ||
| Q2 24 | — | $-9.1M | ||
| Q1 24 | — | $7.2M |
| Q4 25 | — | $-35.2M | ||
| Q3 25 | $6.5M | $8.6M | ||
| Q2 25 | — | $-16.7M | ||
| Q1 25 | — | $-2.5M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $13.4M | ||
| Q2 24 | — | $-9.4M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | — | -72.8% | ||
| Q3 25 | 7.7% | 13.5% | ||
| Q2 25 | — | -32.4% | ||
| Q1 25 | — | -3.5% | ||
| Q4 24 | — | -123.5% | ||
| Q3 24 | — | 146.2% | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | 11.6% |
| Q4 25 | — | 6.9% | ||
| Q3 25 | 8.8% | 1.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 29.4% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.96× | ||
| Q1 24 | — | 9.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
FFWM
Segment breakdown not available.
